The Innovation Team at the CEIH that works directly with innovators seeking to break into the health sector with new ideas, concepts, and inventions, but often their experience is that breaking through is hard. Equally, the team works closely with policy makers, clinicians and administrators who struggle to bring new innovations into the system.
To investigate the factors that determine the success or failure of an innovation, the CEIH hosted a workshop to investigate what it takes to successfully connect the ‘creator’ of the innovation with the ‘consumer’ of the innovation. It was hypothesised that there is a need for ‘catalysts’ between the two that can influence how decisions are made.
The Adopting Innovative Technology workshop featured four industry experts, each with a unique skill set, perspective and experience base as it relates to adopting innovation. Lee Martin, CEO of Lutheran Homes Barossa spoke of his experiences adopting robots into mainstream practice in an aged care facility. Stephen Blakeney, National Innovations Manager at Medical Device Partnering Program shared his significant insights into the process of ideation to production of a medical device, unearthing the stark reality of innovation. Nat Peek, CPO, and Founder of Biomorphik, an Adelaide based health-tech company, offered a front row seat to the life of an innovator trying to navigate and integrate with the health system. Alastair McDonald, Director Strategy and Architecture at Digital health SA delivered a detailed explanation of the real-world challenges of adopting new technologies into the digital systems of government, including those that are warranted, valued, and needed.
The session opened in the context of the newly released CEIH Innovation Model, as a way of recognising the Stages and Steps involved in successful innovation adoption. During their presentations, each speaker highlighted their perspectives relative to each stage and identified a range of issues they felt needed to be considered. The presentations were followed by a Q+A Panel session where the audience and presenters exchanged a number of thoughts and ideas.
Conversations identified that investors and funders often have low financial risk, and coupled with a necessary, but highly regulated landscape, the progression of innovation is often stifled. This can make generating income for innovation complex, unpredictable and time consuming, especially in a context where Government processes can be slow and cumbersome, which further inhibits momentum of innovators.
There was consensus that the value of an innovation is perceived and received differently by different stakeholders, agencies, and consumers throughout the journey, and that leaders set the tone for innovation through visioning, risk-taking, investing and advocating at scale. Consumer engagement in innovation was identified as being critical at all stages and that multiple stakeholders need to be involved in the adoption process at different times for different purposes.
Trust and transparency of processes and goals was deemed critical for shared understanding and authentic collaboration and there was agreement that innovators and consumers both need to be able to pivot and adapt throughout the journey. Key topics requiring further investigation were distilled from the session and are as follows.
- Worth and Value – there is a need to identify the value proposition throughout the journey of the innovation and understand when the investment benefit is returned.
- Authority and Governance – there is a need to find the balance between regulation and appropriate risk taking in decision making.
- Relationships and Interconnections – there is a need to create a system that ensures collaboration and co-design throughout the journey of the innovation.
- Systems and Processes – there is a need to identify and document the operational logistics of progressing an innovation into the health system.
- Data and Information – there is a need to access and mobilise data to identify problems, detect changes and monitor performance of innovations.
Through the Innovation Collaborative, the CEIH will facilitate sessions in 2025 to address issues generated throughout the workshop.
Learn more about the Innovation Collaborative.